Saijo et al. (2017). Single small study with post-mortem Pick’s disease CSF samples and antemortem control samples. Other studies detecting 3R tau seeds have used brain homogenate samples only (Kraus et al., 2019; Metrick et al., 2020; Tennant et al., 2020). The gene discussed is MAPT; the disease is Pick disease.